Page last updated: 2024-11-07

paramethasone and Carcinoma, Renal Cell

paramethasone has been researched along with Carcinoma, Renal Cell in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
UEDA, Y1
MIYAHARA, T1
MINAMI, S1
SAITO, T1
OGURA, Y1

Other Studies

1 other study available for paramethasone and Carcinoma, Renal Cell

ArticleYear
[A CASE OF RENAL CELL CARCINOMA MANIFESTED. A TYPICAL NEPHROTIC SYNDROME].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1964, Jan-10, Volume: 52

    Topics: Adenocarcinoma; Blood Chemical Analysis; Carcinoma, Renal Cell; Humans; Hypoproteinemia; Kidney Func

1964